Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)

About

The Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) provides comprehensive assessment of broadly protective influenza vaccine candidates integrated with fundamental research on protective host responses to provide insight into the mechanisms that drive influenza vaccine effectiveness in the most vulnerable, high-risk populations. Using computational methodologies, broadly reactive hemagglutinin- and neuraminidase-based vaccines are being assessed using cutting-edge scientific and statistical modeling technologies. Additionally, the CIVR-HRP network is investigating novel platforms to deliver universal influenza vaccines, including recombinant proteins, microparticles, live attenuated viruses, and microneedle skin patches. Combining traditional and cutting-edge immunology, epigenetics, structural biology, virology, systems biology, and statistical modeling with various OMICs assessments of host responses to influenza vaccination and infection in high-risk models, the CIVR-HRP is developing the next generation flu vaccines for people and the models needed to predict their effectiveness.

Dr. Ted Ross, Principal Investigator, Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)

Principal Investigator

PROFESSOR, INFECTIOUS DISEASES 

Director of the Center for Vaccines and Immunology

University of Georgia

Dr. Stacey Shultz-Cherry, co-Principal Investigator, Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)

co-Principal Investigator

PROFESSOR, HOST-MICROBE INTERACTIONS 

St. Jude Children’s Research Hospital

Investigators

University of Georgia

  • Andreas Handel, PhD, Associate Professor, Department of Epidemiology and Biostatistics
  • Ye Shen, PhD, Associate Professor, Department of Epidemiology and Biostatistics

St. Jude Children’s Research Hospital

Auburn University

Case Western Reserve University

  • Stephanie Langel, PhD, Assistant Professor, Department of Pathology, Center for Global Health and Diseases, School of Medicine

Cleveland Clinic

  • Giuseppe Sautto, PhD, MBA, Assistant Professor, Florida Innovation and Research Center
  • Giovana Hood, Research Database Specialist

Duke University

Florida State University

  • Jarrod Mousa, PhD, Associate Professor, Department of Biomedical Sciences

Icahn School of Medicine at Mount Sinai

Mayo Clinic

National Institute of Allergy and Infectious Diseases

New York University

New York University Langone Health

  • Drew Jones, PhD, Assistant Professor, Department of Biochemistry and Molecular Pharmacology, NYU Metabolomics Core Resource Laboratory

Ragon Institute of MGH, MIT, and Harvard

University of Alberta

University of California at Los Angeles

University of California at Santa Cruz

University of Colorado

  • Jenna Guthmiller, PhD, Assistant Professor, Department of Immunology & Microbiology, University of Colorado Anschutz School of Medicine

University of Kentucky

University of Melbourne at the Peter Doherty Institute 

University of Montana

University of North Carolina

University of Rochester

University of Pennsylvania

University of Texas

Vanderbilt University

Other Key Personnel

Research Managers

  • Michael Carlock, Project Manager, Florida Innovation and Research Center, Cleveland Clinic

Center Data Manager

  • Donald Carter, Research Database Specialist, AVCBioData Management

Center Coordinator

  • Kali King, MBA, Business Coordinator, Center for Vaccines and Immunology, University of Georgia
  • James Allen, Program Director/Research Associate, Florida Research and Innovation Center, Cleveland Clinic
  • Tristan Erdman, Business Manager, Florida Innovation and Research Center, Cleveland Clinic